Barr Laboratory BRL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Barr Laboratory BRL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Silverman who wrote (77)	10/22/1997 11:08:00 PM
From: harkenman	Read Replies (1) of 207

Barr Labs Gets FDA OK To Sell Estradiol Tablets Dow Jones Newswires POMONA, N.Y. -- Barr Laboratories Inc. (BRL) received clearance from the Food and Drug Administration to market Estradiol Tablets, the generic equivalent of Bristol-Myers Squibb Co.'s (BMY) Estrace, for treating symptoms of menopause and preventing osteoporosis. In a press release Wednesday, Barr Laboratories said Estradiol will be available in three strengths - 0.5 mg, 1 mg and 2 mg. The company said the hormonal agent is used to treat severe vasomotor symptoms associated with menopause and for preventing osteoporosis. Barr Laboratories is the third company to bring a generic version of the product to market. Barr Laboratories develops, makes and marekts generic pharmaceuticals.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next